PreVisit AI
RN

Margaret Chen, 72F

Last Visit: Dec 12, 2025

Visit Reason

Follow-up: Heart failure management after ER visit (Mar 15), renal function decline, medication review

Sulfa drugs (rash)ACE inhibitors (angioedema)

Key Medications

Furosemide40 mgBID
Empagliflozin10 mgDaily
Carvedilol25 mgBID
Losartan100 mgDaily

Active Conditions

AI-inferred from recent encounters, labs, and medications

Risk Assessment

HIGHHeart Failure Exacerbation
87%
  • ER visit for acute dyspnea with O2 sat 89% (Mar 15, 2026)
  • Progressive eGFR decline: 62 → 48 over 11 months
  • BNP trending upward: 380 → 620 pg/mL

Missing data: Echocardiogram — last done Feb 2025 (14 months ago)

MODERATECKD Progression
72%
  • eGFR declined 23% in 11 months (62 → 48)
  • Proteinuria present on last urinalysis (Oct 8, 2025)

Missing data: Nephrology consult — never referred despite eGFR <60

LOWDepression Screening
45%
  • PHQ-2 score of 3 at last visit (Dec 12, 2025)
  • Social isolation noted in nursing intake (Dec 12, 2025)

Missing data: Full PHQ-9 screening — PHQ-2 was positive but full assessment not completed

Since Last Visit

Mar 15, 2026

ER visit for shortness of breath

View source →

Feb 28, 2026

Furosemide increased to 40mg BID

View source →

Feb 10, 2026

Lab: eGFR 48, Cr 1.4, HbA1c 7.2%

View source →

Jan 22, 2026

Started Empagliflozin 10mg daily

View source →

Deep link to EHR available with FHIR integration

Recent Changes

Medication Changes

~Feb 28, 2026Furosemide increased from 20mg daily to 40mg BID
+Jan 22, 2026Empagliflozin 10mg daily started

ED Visits / Hospitalizations

Mar 15, 2026ER visit — shortness of breath, O2 sat 89%, discharged after 6hr observation

Imaging Results

Mar 15, 2026Chest X-ray: mild pulmonary congestion, bilateral pleural effusions (new)

Critical Lab Changes

Feb 10, 2026eGFR dropped to 48 (was 55 in Oct 2025) — approaching Stage 3b CKD

Deep link to EHR available with FHIR integration

Care Gaps

Overdue: Echocardiogram (14 months overdue)
Overdue: Nephrology referral (6 months overdue)
Due Soon: PHQ-9 screening (Due this visit)
Overdue: Annual eye exam (8 months overdue)

Key Trends

eGFR

48 mL/min/1.73m²

HbA1c

7.2%

Weight

173 lbs

Blood Pressure

125/78 mmHg

Suggested Questions

  • 1How has your breathing been since the ER visit on March 15th?
  • 2Have you been able to follow the low-sodium diet and monitor your weight daily?
  • 3Are you experiencing any side effects from the Empagliflozin we started in January?

Click questions to select for your visit

Was this briefing accurate and useful?